Please assess the completion status of the following clinical trial:

Trial Title: BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Be at least 18 years of age~* Have been histologically diagnosed with invasive adenocarcinoma of the prostate, at clinical stage T1-T3 (as determined by a biopsy taken within 9 months of the screening visit)~* Be scheduled for radiation therapy (XRT) by means of IMRT~Exclusion Criteria:~* Any prior invasive malignancy (except non-melanomatous skin cancer) unless the subject has been disease free for a minimum of 5 years~* Prior radical prostatectomy~* Prior cryosurgery or radiotherapy for prostate cancer, or other local therapy for prostate cancer~* Prior radiotherapy to the pelvis, including brachytherapy~* History of prior surgery involving the rectum or anus~* Prior surgical procedure involving the peri-rectal and/or peri-prostatic area

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- balloon group (Type: EXPERIMENTAL): Marking + balloon implantation + IMRT
- Control group (Type: SHAM_COMPARATOR): Marking + IMRT

Based on this trial design, predict the completion outcome and termination type (if applicable).